Advertisement
Cardiovascular
Subscribe to Cardiovascular
View Sample

FREE Email Newsletter

Fresenius Medical Care introduces 2008K@homeâ„¢ hemodialysis delivery system in North America

November 11, 2011 4:50 am | News | Comments

BAD HOMBURG, Germany--(BUSINESS WIRE)--Fresenius Medical Care AG & Co. KGaA (“the company” or “Fresenius Medical Care”; Frankfurt Stock Exchange: FME / New York Stock Exchange: FMS), the world's largest provider of dialysis products and services, today introduced the 2008K@home...

St. Jude Medical Portico Transcatheter Valve Demonstrates Promising Results in Feasibility Study

November 11, 2011 4:40 am | News | Comments

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the feasibility study results for the company's Porticoâ„¢ Transcatheter Aortic Heart Valve, presented at the 23rd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.

Flexible Stenting Solutions, Inc. Announces First Implant of the 200 mm FlexStent® Femoropopliteal Self Expanding Stent System

November 10, 2011 5:56 am | News | Comments

EATONTOWN, N.J.--(BUSINESS WIRE)--Flexible Stenting Solutions, Inc. (FSS), a leading developer of next generation peripheral arterial, venous, neurovascular and biliary stents, announced today the successful implantation of its 200 mm FlexStent® Femoropopliteal Self Expanding Stent System...

Advertisement

PROTECT II Demonstrates That Patients Undergoing Extensive Revascularization Benefit the Most from Impella Support

November 10, 2011 5:22 am | News | Comments

DANVERS, Mass. & SAN FRANCISCO--(BUSINESS WIRE)--Abiomed Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced the final analysis from the PROTECT II trial at the annual 2011 Transcatheter Cardiovascular Therapeutics (TCT) meeting.

1st Findings on Exercise Performance with SynCardia's Total Artificial Heart Published in The Journal of Heart and Lung Transplantation

November 10, 2011 5:02 am | News | Comments

TUCSON, Ariz. – Nov. 10, 2011 – In the November issue of The Journal of Heart and Lung Transplantation (JHLT), Virginia Commonwealth University (VCU) Medical Center in Richmond published the first findings demonstrating that physical exercise and measurable rehabilitation are feasible with the SynCardia...

Svelte Medical Systems Announces Treatment of First Patient in the DIRECT Drug-Eluting Stent Study

November 9, 2011 4:44 am | News | Comments

NEW PROVIDENCE, N.J.--(BUSINESS WIRE)--Svelte® Medical Systems today announced treatment of the first patient in the DIRECT (Direct-on-a-wire Implantation of Rapamycin-eluting stent with bio-Eroding Carrier Technology) study at Auckland City Hospital in Auckland, New Zealand.

Positive Long Term Clinical Data of the Cappella Sideguard® Stent System Announced at TCT 2011

November 9, 2011 4:38 am | News | Comments

SAN FRANCISCO--(BUSINESS WIRE)--Cappella Medical Devices Ltd (Cappella), a medical device company developing dynamic solutions for the treatment of coronary bifurcation disease, announced today at the 2011 TCT (Transcatheter Cardiovascular Therapeutics) Conference in San Francisco...

Study of Medtronic Endeavor® Drug-Eluting Stent Demonstrates Long-Term Advantages over Taxus® DES

November 9, 2011 4:26 am | News | Comments

SAN FRANCISCO--(BUSINESS WIRE)--New research findings released at TCT 2011 show that the Endeavor® zotarolimus-eluting stent (DES) from Medtronic, Inc. (NYSE: MDT) outperformed Boston Scientific Corp.'s Taxus® paclitaxel-eluting stent on standard measures of safety and efficacy through five years of clinical follow-up.

Advertisement

Getinge Group: Getinge finalizes the acquisition of Atrium Medical Inc. and changes the date of its AGM

November 8, 2011 5:04 am | News | Comments

Getinge has been granted the approval of US anti-trust authority FTC (Federal Trade Commission) to go ahead with the acquisition of Atrium Medical Inc. The acquisition was finalized on 4 November, 2011, and will be consolidated in Getinge's accounts as of 1 November this year.

Medtronic CoreValve® System Gains CE Mark for New Direct Aortic Approach to Transcatheter Aortic Valve Implantation

November 8, 2011 4:54 am | News | Comments

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE: MDT) today announced it has received CE (Conformité Européenne) Mark for the Medtronic CoreValve® System to be delivered using direct aortic access. The Medtronic CoreValve System is now the only transcatheter aortic valve implantation (TAVI) system...

Terason Quickens the Pulse of Vascular Ultrasound with New Portable System

November 7, 2011 5:47 am | News | Comments

BURLINGTON, Mass.--(BUSINESS WIRE)--The pulse of vascular ultrasound quickens with the release of the new Terason t3200â„¢ Vascular Series Ultrasound System. The t3200 is the first fully-functional, portable ultrasound system designed specifically for the vascular professional.

Miracor to Report Successful Clinical Study Results of Its PICSO® System Designed to Improve Myocardial Perfusion Following Primary PCI

November 7, 2011 5:45 am | News | Comments

VIENNA--(BUSINESS WIRE)--Miracor Medical Systems GmbH announced today that data will be reported during next week's “TCT (Transcatheter Cardiovascular Therapeutics) 2011” scientific meeting in San Francisco. The data show that the PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) system...

Lake Region Medical to Showcase New and Emerging Technologies That Positions the Company as a Premier Development and Manufacturing Partner for Wire-Based Products at Cardiovascular Therapy Meeting

November 4, 2011 6:43 am | News | Comments

MINNEAPOLIS--(BUSINESS WIRE)--Lake Region Medical, a global development and manufacturing partner to leading medical device companies, will highlight its original development manufacturing capabilities, services and technologies at the 23rd annual Transcatheter Cardiovascular Therapeutics (TCT) meeting...

Advertisement

Emboline, Inc. to Debut Game-Changing Embolic Protection Technology for Percutaneous Heart Valve Procedures in San Francisco Next Week

November 4, 2011 6:40 am | News | Comments

FREMONT, Calif.--(BUSINESS WIRE)--Emboline, Inc. (www.emboline.com), an emerging medical device company, will debut its game-changing embolic protection devices for percutaneous heart valve repair and replacement in San Francisco next week. The Company is initially focused on developing...

First Comprehensive Study on How Physicians Use Digital Sources to Find Medical Device Information Now Available

November 4, 2011 6:33 am | News | Comments

TORONTO--(BUSINESS WIRE)--Millennium Research Group (MRG), the global authority on medical technology market intelligence, announced today that it will be marketing the Manhattan Research product Digital MedTech Physicianâ„¢, the first data-intense study of how physicians use digital channels...

Arterial Remodeling Technologies (“ART") reports that its second-generation bioresorbable stent promotes vessel lumen enlargement in post-angioplasty in vivo model

November 2, 2011 8:23 pm | News | Comments

PARIS--(BUSINESS WIRE)--Arterial Remodeling Technologies (“ART”) reported today that in vivo data strongly suggest that its second-generation bioresorbable stent promotes positive arterial remodeling in a post-angioplasty porcine model at three months follow-up.

Medtronic Begins Transcatheter Aortic Valve Trial in Japan

November 2, 2011 8:09 pm | News | Comments

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE: MDT) today announced the first implant in a clinical trial in Japan that will evaluate the safety and effectiveness of the Medtronic CoreValve® System. The successful procedure in the trial was led by Professor Yoshiki Sawa

New Brain Aneurysm Treatment at Stanford Hospital Supplies Hope

November 2, 2011 4:22 am | News | Comments

STANFORD, Calif.--(BUSINESS WIRE)--If Barbara Maluo's brain aneurysm had been discovered a few months ago, she would have had few viable treatment options. She was one of the 10 to 15 percent of brain aneurysm patients diagnosed each year with aneurysms so large and wide...

ROX Medical Announces First Clinical Use of the ROX FLO2W Procedure for the Treatment of High Blood Pressure in Resistant Hypertension Patients

November 1, 2011 8:42 pm | News | Comments

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--ROX Medical, Inc., a world leader in the development of unique minimally invasive medical devices for the treatment of advanced COPD and resistant hypertension, today announced the first clinical use of the ROX CO2UPLERTM at the Universitair Ziekenhuis Brussel...

Medtronic Receives First FDA Approval of Cobalt Chromium Balloon-Expandable Stent to Treat Narrowed Iliac Arteries

October 31, 2011 9:14 am | News | Comments

MINNEAPOLIS –– Oct. 31, 2011 –– Advancing the treatment of peripheral artery disease, Medtronic, Inc. (NYSE: MDT) today announced approval by the U.S. Food and Drug Administration (FDA) of the Assurant® Cobalt Iliac Balloon-Expandable Stent System.

Physician Prescriptions for ZOLL LifeVest Top 50,000

October 28, 2011 10:33 am | News | Comments

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation (NasdaqGS: ZOLL), a manufacturer of medical devices and related software solutions, announced today that more than 50,000 patients at high risk of sudden cardiac arrest (SCA) have been prescribed the LifeVest® Wearable Defibrillator.

FDA Advisory Panel Makes Recommendation on Investigational Medtronic Phased RF Ablation System for Treatment of Persistent or Long-Standing Persistent Atrial Fibrillation

October 28, 2011 7:44 am | News | Comments

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE: MDT) today announced that the U.S. Food and Drug Administration's (FDA) Circulatory Systems Devices advisory panel voted against the Medtronic Phased RF Ablation System, the first atrial fibrillation ablation therapy under investigation...

Boston Biomedical Associates helps AtriCure's Synergy Ablation System win a Recommendation from FDA Expert Advisors

October 28, 2011 7:39 am | News | Comments

NORTHBOROUGH, Mass.--(BUSINESS WIRE)--Boston Biomedical Associates today announced that AtriCure, Inc., a medical device company and a leader in cardiac surgical ablation systems and devices for the exclusion of the left atrial appendage, received a vote of approval support...

Avinger Debuts Kittycat 2 Catheter and Juicebox in US and EU Markets, Two Innovative Tools for the Treatment of Peripheral Artery Disease (PAD)

October 27, 2011 11:57 am | News | Comments

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Avinger, Inc., a medical device manufacturer of innovative, multi-functional catheters for treating patients with Peripheral Artery Disease (PAD), announces today the release of two new products, Kittycat 2, a smaller more refined ultimate support catheter, and Juicebox...

Medtronic Starts Landmark Study of Hypertension Treatment

October 27, 2011 11:36 am | News | Comments

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic Inc. (NYSE: MDT) announced today the start of SYMPLICITY HTN-3, the company's U.S. clinical trial of the Symplicity® Renal Denervation System™ for treatment-resistant hypertension. The first patient in this landmark study was enrolled at the Prairie Heart Institute at St. John's Hospital in Springfield, Ill.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading